Seroprevalence of dengue infection: A cross-sectional survey in mainland Tanzania and on Pemba Island, Zanzibar

International Journal of Infectious Diseases

Volumn 16, Issue 1, 2012, Pages

  Vairo, Francesco ^a,b,c   Nicastri, Emanuele ^a   Meschi, Silvia ^a   Schepisi, Monica Sanè ^a   Paglia, Maria Grazia ^a   Bevilacqua, Nazario ^a   Mangi, Sabina ^d   Sciarrone, Maria Rosaria ^a   Chiappini, Roberta ^a   Mohamed, Jape ^e   Racalbuto, Vincenzo ^b   Di Caro, Antonino ^a   Capobianchi, Maria Rosaria ^a   Ippolito, Giuseppe ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b Italian Ministry of Foreign Affairs   (Italy)

^c Italian Development Cooperation   (Tanzania)

^d Tosamaganga Missionary Hospital   (Tanzania)

^e Public Health Laboratory Ivo De Carneri   (Tanzania)

Author keywords

Dengue; Seroprevalence; Tanzania

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; FEMALE; HEALTH SURVEY; HOSPITAL; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; TANZANIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DENGUE; DENGUE VIRUS; FEMALE; FEVER; HUMANS; INCIDENCE; INDIAN OCEAN ISLANDS; INFANT; MALE; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; TANZANIA;

EID: 84855299420     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.09.018     Document Type: Article

References (16)

1. World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control. New edition. Geneva: World Health Organization; 2009. Available at: .(accessed July 29, 2010). http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf.
2. Franco L., Di Caro A., Carletti F., Vapalahti O., Renaudat C., Zeller H., et al. Recent expansion of dengue virus serotype 3 in West Africa. Euro Surveill 2010, 15:19490.
3. Boisier P., Morvan J.M., Laventure S., Charrier N., Martin E., Ouledi A., et al. Dengue 1 epidemic in the Grand Comoro Island (Federal Islamic Republic of the Comores), March-May 1993. Ann Soc Belg Med Trop 1994, 74:217-229.
4. Gubler D.J., Sather G.E., Kuno G., Cabral J.R. Dengue 3 virus transmission in Africa. Am J Trop Med Hyg 1986, 35:1280-1284.
5. Rodier G.R., Gubler D.J., Cope S.E., Cropp C.B., Soliman A.K., Polycarpe D., et al. Epidemic dengue 2 in the city of Djibouti 1991-1992. Trans R Soc Trop Med Hyg 1996, 90:237-240.
6. Blaylock JM, Maranich A, Bauer K, Nyakoe N, Waitumbi J, Martinez LJ, Lynch J. The seroprevalence and seroincidence of dengue virus infection in western Kenya. Travel Med Infect Dis 2011 Jul 19.[Epub ahead of print].
7. Sharp T.W., Wallace M.R., Hayes C.G., Sanchez J.L., DeFraites R.F., Arthur R.R., et al. Dengue fever in US troops during Operation Restore Hope, Somalia, 1992-1993. Trans R Soc Trop Med Hyg 1995, 53:89-94.
8. Moi M.L., Takasaki T., Kotaki A., Tajima S., Lim C.K., Sakamoto M., et al. Importation of dengue virus type 3 to Japan from Tanzania and Cote d'Ivoire. Emerg Infect Dis 2010, 16:1770-1772.
9. Gautret P., Simon F., Hervius Askling H., Bouchaud O., Leparc-Goffart I., Ninove L., et al. EuroTravNet. Dengue type 3 virus infections in European travelers returning from the Comoros and Zanzibar, February-April 2010. Euro Surveill 2010, 15:19541.
10. Ippolito G. Dengue-Italy ex Tanzania. ProMED-mail 2010 Jul 9. Available at: , archive number 20100709.2304.(accessed the 10th of July 2011). http://www.promedmail.org/.
11. Klaassen B. Dengue/DHF update 2010 (23). Tanzania (Dar es Salaam). ProMED-mail 2010 May 17. Available at: , archive number 20100517.1620.(accessed on the 1st of June 2011). http://www.promedmail.org/.
12. Nicastri E., Bevilacqua N., Sañé Schepisi M., Paglia M.G., Meschi S., Ame S.M., et al. Accuracy of malaria diagnosis by microscopy, rapid diagnostic test, and PCR methods and evidence of antimalarial overprescription in non-severe febrile patients in two Tanzanian hospitals. Am J Trop Med Hyg 2009, 80:712-717.
13. World Health Organization, 2001. Monitoring antimalarial drug resistance. Report of a WHO consultation, Geneva, Switzerland, 3-5 December 2001. WHO/CDS/CSR/EPH/2002.17. Geneva: World Health Organization; 2002. Available at: (accessed on the 24 of May 2011). http://www.who.int/drugresistance/publications/WHO_CDS_CSR_EPH_2002_17/en/index.html.
14. Niedrig M., Zeller H., Schuffenecker I., Drosten C., Emmerich P., Rumer L., et al. International diagnostic accuracy study for the serological detection of chikungunya virus infection. Clin Microbiol Infect 2009, 15:880-884.
15. Scaramozzino N., Crance J.M., Jouan A., DeBriel D.A., Stoll F., Garin D. Comparison of flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences. J Clin Microbiol 2001, 39:1922-1927.
16. Hasebe F., Parquet M.C., Pandey B.D., Mathenge E.G., Morita K., Balasubramaniam V., et al. Combined detection and genotyping of Chikungunya virus by a specific reverse transcription-polymerase chain reaction. J Med Virol 2002, 67:370-374.